The Bacterial Flora in Inflammatory Bowel Disease: Current Insights in Pathogenesis and the Influence of Antibiotics and Probiotics

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Scandinavian Journal of Gastroenterology, Supplement

• Publication date

  2001-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/003655201753265082PMID 11768558
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection of immunoreactive antigen, with a monoclonal antibody to measles virus, in tissue from a patient with Crohn's disease

  2005cited by this paper
• Application of denaturing gradient gel electrophoresis (DGGE) and temperature gradient gel electrophoresis (TGGE) in microbial ecology

  2004cited by this paper
• Real-Time Quantitative PCR

  2002cited by this paper
• Viruses and Inflammatory Bowel Disease: Is There Evidence for a Causal Association?

  2000cited by this paper
• Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease

  2000cited by this paper
• Immunohistochemical analysis of the distribution of measles related antigen in the intestinal mucosa in inflammatory bowel disease

  2000cited by this paper
• Probiotics and inflammatory bowel diseases.

  2000cited by this paper
• Genetics of Inflammatory Bowel Disease: A Reappraisal

  2000cited by this paper
• Polymorphisms in tumour necrosis factor and adhesion molecule genes in patients with inflammatory bowel disease: associations with HLA-DR and -DQ alleles and subclinical markers.

  1999cited by this paper
• Circulating antibodies to Saccharomyces cerevisiae (bakers'/brewers' yeast) in gastrointestinal disease.

  1999cited by this paper
• Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial.

  1999cited by this paper
• Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis

  1999cited by this paper
• A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease

  1999cited by this paper
• Infectious agents and Crohn's disease.

  1999cited by this paper
• The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls.

  1999cited by this paper
• The effect of probiotic bacteria on the adhesion of pathogens to human intestinal mucus.

  1999cited by this paper
• Antibiotic combination therapy in patients with chronic, treatment‐resistant pouchitis

  1999cited by this paper
• Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative?

  1999cited by this paper
• HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis

  1999cited by this paper
• Paramyxovirus infections in childhood and subsequent inflammatory bowel disease.

  1999cited by this paper
• Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial.

  1999cited by this paper
• Nutrition and inflammatory bowel disease: an update.

  1999cited by this paper
• Antiinflammatory effects of enterically coated amoxicillin-clavulanic acid in active ulcerative colitis.

  1998cited by this paper
• Antiinflammatory Effects of Enterically Coated Amoxicillin‐Clavulanic Acid in Active Ulcerative Colitis

  1998cited by this paper
• Combination ciprofloxacin and metronidazole for active Crohn's disease.

  1998cited by this paper
• Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease.

  1998cited by this paper
• Anti-Saccharomyces cerevisiae mannan antibodies in familial crohn’s disease

  1998cited by this paper
• Life-threatening complications of IBD: How to handle fulminant colitis and toxic megacolon: Clinical features, key diagnostic tests, and treatment options

  1998cited by this paper
• Inflammatory Bowel Disease and Smoking—A Review

  1998cited by this paper
• IgM antibody against measles virus in patients with inflammatory bowel disease: a marker of virus related disease?

  1998cited by this paper
• HLA-DRB1*03, but not the TNFα-308 promoter polymorphism confers protection against fistulizing Crohn's disease

  1998cited by this paper
• Absence of Escherichia coli, Listeria monocytogenes, and Klebsiella pneumoniae antigens within inflammatory bowel disease tissues.

  1998cited by this paper
• Controlled trial of antituberculous chemotherapy in Crohn’s disease: a five year follow up study

  1998cited by this paper
• Maintenance treatment of chronic pouchitis: A randomised placebo-controlled, double-blind trial with A new probiotic preparation

  1998cited by this paper
• Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease.

  1998cited by this paper
• Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease

  1998cited by this paper
• Ecological control of the gastrointestinal tract. The role of probiotic flora

  1998cited by this paper
• Inflammatory bowel disease: etiology and pathogenesis.

  1998cited by this paper
• The Role of the Fecal Stream in Crohn's Disease: An Historical and Analytic Review

  1998cited by this paper
• Use of antibiotics in the treatment of active Crohn's disease: experience with metronidazole and ciprofloxacin.

  1998cited by this paper
• HLA-DRB1*03, but not the TNFA -308 promoter gene polymorphism, confers protection against fistulising Crohn’s disease

  1998cited by this paper
• Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum.

  1998cited by this paper
• Anti-Saccharomyces cerevisiae Mannan Antibodies in Familial Crohn's Disease

  1998cited by this paper
• Postoperative recurrence of Crohn's disease: the enemy is within the fecal stream.

  1998cited by this paper
• Is measles infection associated with Crohn's disease?

  1998cited by this paper
• Controlled trial of antituberculous chemotherapy in Crohn's disease: a five year follow up study.

  1998cited by this paper
• Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease.

  1997cited by this paper
• Appendectomy and the risk of developing ulcerative colitis or Crohn's disease: results of a large case-control study. South Limburg Inflammatory Bowel Disease Study Group.

  1997cited by this paper
• Spondyloarthropathy and idiopathic inflammatory bowel diseases.

  1997cited by this paper
• A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis.

  1997cited by this paper
• Spontaneously colitic C3H/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora.

  1997cited by this paper
• T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment.

  1997cited by this paper
• Mucosa-associated bacterial flora of the human colon.

  1997cited by this paper
• Seasonal variation in exacerbations of ulcerative colitis.

  1997cited by this paper
• Factors influencing the relapse of patients with inflammatory bowel disease.

  1997cited by this paper
• Crohn's disease and measles.

  1997cited by this paper
• IgM antibody against measles virus in patients with inflammatory bowel disease: a marker of virus‐related disease?

  1997cited by this paper
• Double‐blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis

  1997cited by this paper
• Absence of measles viral genomic sequence in intestinal tissues from Crohn's disease by nested polymerase chain reaction.

  1996cited by this paper
• Digestion, excretion, and energy value of fructooligosaccharides in healthy humans.

  1996cited by this paper
• Unifying hypothesis for inflammatory bowel disease and associated colon cancer: sticking the pieces together with sugar.

  1996cited by this paper
• An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin.

  1996cited by this paper
• Real time quantitative PCR.

  1996cited by this paper
• Crohn's disease after in-utero measles virus exposure.

  1996cited by this paper
• Environmental risk factors in inflammatory bowel disease.

  1996cited by this paper
• Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG.

  1996cited by this paper
• Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD)

  1996cited by this paper
• Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection.

  1995cited by this paper
• IgM-specific measles-virus antibody in families with a high frequency of Crohn's disease.

  1995cited by this paper
• Immunocytochemical evidence of Listeria, Escherichia coil, and Streptococcus antigens in Crohn's disease

  1995cited by this paper
• Perinatal measles infection and subsequent Crohn's disease

  1995cited by this paper
• Fluorescently labelled, rRNA‐targeted oligonucleotide probes in the study of microbial ecology

  1995cited by this paper
• Mycobacterium paratuberculosis and Crohn's disease.

  1995cited by this paper
• Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin.

  1995cited by this paper
• Gut flora in normal and disordered states.

  1995cited by this paper
• Colonization resistance

  1994cited by this paper
• Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment.

  1994cited by this paper
• Antibiotics in inflammatory bowel disease: new choices for an old disease.

  1994cited by this paper
• Perinatal measles infection and subsequent Crohn's disease.

  1994cited by this paper
• Smoking: Good or Bad for Inflammatory Bowel Disease?

  1994cited by this paper
• Smoking: good or bad for inflammatory bowel disease?

  1994cited by this paper
• Alterations in the mucosal immune system in ulcerative colitis and Crohn's disease.

  1994cited by this paper
• Pouchitis: result of microbial imbalance?

  1994cited by this paper
• Pouchitis following heal pouch-anal anastomosis: Definition, pathogenesis, and treatment

  1994cited by this paper
• Childhood infections and the risk of inflammatory bowel disease

  1994cited by this paper
• Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis

  1994cited by this paper
• Intravenous tobramycin and metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis.

  1994cited by this paper
• Is there a role for antibiotics as primary therapy in Crohn's ileitis?

  1993cited by this paper
• Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat.

  1993cited by this paper
• Oral tobramycin in ulcerative colitis: effect on maintenance of remission

  1993cited by this paper
• Antibodies to Mycobacterium paratuberculosis and nine species of environmental mycobacteria in Crohn's disease and control subjects.

  1993cited by this paper
• Evidence of persistent measles virus infection in Crohn's disease

  1993cited by this paper
• In situ PCR

  1993cited by this paper
• Seasonal variation in exacerbations of ulcerative colitis.

  1993cited by this paper
• Are Antibiotics Useful in the Management of Nontoxic Severe Ulcerative Colitis?

  1993cited by this paper
• The effect of dietary yeast on the activity of stable chronic Crohn's disease.

  1992cited by this paper
• Identification of the uncultured bacillus of Whipple's disease.

  1992cited by this paper
• The rectal mucosa-associated microflora in patients with ulcerative colitis.

  1992cited by this paper
• The role of the mucosal immune system in inflammatory bowel disease.

  1992cited by this paper
• Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance.

  1992cited by this paper

• Targeting IBD treatment: smart drug delivery systems for oral administration

  2026cites this paper
• Progress in the investigation of the Firmicutes/Bacteroidetes ratio as a potential pathogenic factor in ulcerative colitis.

  2025cites this paper
• A Comprehensive Analysis of Efficacy and Safety of Probiotics in Inflammatory Bowel Disease

  2024cites this paper
• Increased Risk of Inflammatory Bowel Disease Among Patients With Nontyphoidal Salmonella Infections: A Population-Based Cohort Study.

  2024cites this paper
• Targeting the Gut: A Systematic Review of Specific Drug Nanocarriers

  2024cites this paper
• Microbial harmony in female reproductive health: exploring the impact of intestinal flora on ovarian function and disease pathogenesis.

  2024cites this paper
• Mucin glycans and their degradation by gut microbiota

  2023cites this paper
• Amoebiasis and probiotics: perspectives on complementary treatment

  2023cites this paper
• Vaginal epithelial drug delivery.

  2022cites this paper
• Bile Acids and the Microbiome: Making Sense of This Dynamic Relationship in Their Role and Management in Crohn's Disease

  2022cites this paper
• Colonic delivery of surface charge decorated nanocarrier for IBD therapy

  2022cites this paper
• Advanced drug delivery system in colorectal cancer

  2021cites this paper
• Curcumin ameliorated dextran sulfate sodium-induced colitis via regulating the homeostasis of DCs and Treg and improving the composition of the gut microbiota

  2021cites this paper
• Serum Sickness Like Disease in Children

  2021cites this paper
• Recent Update on Nanomedicine-Based Drug Targeting on Colon Cancer

  2021cites this paper
• Advances in Oral Drug Delivery for Regional Targeting in the Gastrointestinal Tract - Influence of Physiological, Pathophysiological and Pharmaceutical Factors

  2020cites this paper
• Role of Saccharomyces boulardii in inflammatory bowel disease

  2020cites this paper
• USE OF METABOLOMICS TO THE DIAGNOSIS OF INFLAMMATORY BOWEL DISEASE.

  2020cites this paper
• Edwardsiella tarda Infection Triggering Acute Relapse in Pediatric Crohn's Disease

  2019cites this paper
• Evaluation of a microbial muramidase supplementation on growth performance, apparent ileal digestibility, and intestinal histology of broiler chickens

  2019cites this paper
• Evaluation of Technological and Probiotic Abilities of Local Lactic Acid Bacteria

  2019cites this paper
• Fecal IgA Levels and Gut Microbiota Composition Are Regulated by Invariant Natural Killer T Cells.

  2019cites this paper
• Changes in The Expression of Somatostatin (SOM) in Nerve Fibers of Gastrointestinal Mucosa in Dogs with Inflammatory Bowel Disease (IBD)

  2019influential citation
• Microbial dysbiosis in inflammatory bowel diseases: results of a metagenomic study in Saudi Arabia.

  2019cites this paper
• Review of the effects of silver nanoparticle exposure on gut bacteria

  2018cites this paper
• Potential Synergies of β-Hydroxybutyrate and Butyrate on the Modulation of Metabolism, Inflammation, Cognition, and General Health

  2018cites this paper
• Advancements in nanotechnology for drug delivery

  2018cites this paper
• Recent advancements in nanoparticle based drug delivery for gastrointestinal disorders

  2018cites this paper
• Inflammatory arthritis complicated by inflammatory bowel disease: two case reports.

  2017cites this paper
• Risk of inflammatory bowel disease in patients with rosacea: Results from a nationwide cohort study in Taiwan

  2017cites this paper
• Bifidobacterium longum affects the methylation level of forkhead box P3 promoter in 2, 4, 6-trinitrobenzenesulphonic acid induced colitis in rats.

  2017cites this paper
• Targeted delivery of anti-inflammatory drugs in lower parts of gastrointestinal tract: Conventional and novel approaches

  2017cites this paper
• Effects of Natural and Chemically Defined Nutrients on Candida albicans Water-soluble Fraction (CAWS) Vasculitis in Mice.

  2017cites this paper
• Gut–lung axis: The microbial contributions and clinical implications

  2017cites this paper
• Personalizing protein nourishment

  2017cites this paper
• Polymer-based drug delivery: the quest for local targeting of inflamed intestinal mucosa

  2017cites this paper
• Investigating the effects of oryzatensin on gut microbiota growth using a novel quantitative standard curve-fitting method: an ex-vivo study

  2017cites this paper
• Immunological and microbiological studies in post-operative Crohn's disease

  2017cites this paper
• Optimization Of Growth Conditions Of "eubacterium Hallii" As A Potential Probiotics

  2017cites this paper
• A pseudo-kinetics approach for time-series metabolomics investigations: more reliable and sensitive biomarkers revealed in vincristine-induced paralytic ileus rats

  2016cites this paper
• Fatal Clostridium perfringens Septicemia After Colonoscopic Polypectomy, Without Bowel Perforation

  2016cites this paper
• Are There Healthy Sweeteners: The Effects of Sugar Substitutes on the Gut Microbiome - eScholarship

  2016cites this paper
• The influence of some dietary components on intestinal microbiota

  2016influential citation
• Stimuli-responsive polymers for antimicrobial therapy: drug targeting, contact-killing surfaces and competitive release

  2016cites this paper
• Lower Level of Bacteroides in the Gut Microbiota Is Associated with Inflammatory Bowel Disease: A Meta-Analysis

  2016cites this paper
• PROBIOTIC APPROACHES FOR TARGETING INFLAMMATORY BOWEL DISEASE: AN UPDATE ON ADVANCES AND OPPORTUNITIES IN MANAGING THE DISEASE.

  2016cites this paper
• The immunology of the vermiform appendix: a review of the literature

  2016cites this paper
• Ecophysiology and philogeny of Faecalibacterium prausnitzii in healthy and diseased gut. Application in Inflamatory Bowel Disease diagnostics

  2016cites this paper
• Intestinal barrier dysfunction in human necrotizing enterocolitis.

  2016cites this paper
• Advanced Vaccine Research Methods for the Decade of Vaccines

  2016cites this paper
• Anaerobes as Sources of Bioactive Compounds and Health Promoting Tools.

  2016cites this paper
• Research Advance in Intestinal Mucosal Barrier and Pathogenesis of Crohn's Disease

  2016cites this paper
• Environmental Factors in the Relapse and Recurrence of Inflammatory Bowel Disease: A Review of the Literature

  2015cites this paper
• Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue.

  2015cites this paper
• A Prospective, Randomized, Blinded, Placebo‐Controlled Pilot Study on the Effect of Enterococcus faecium on Clinical Activity and Intestinal Gene Expression in Canine Food‐Responsive Chronic Enteropathy

  2015cites this paper
• Galanin - Immunoreactive Nerve Fibers in the Mucosal Layer of the Canine Gastrointestinal Tract During Inflammatory Bowel Disease

  2015cites this paper
• Vergleich der TLR9-abhängigen Aktivierung von Transkriptionsfaktoren in intestinalen Immunzellen unter gesunden und chronisch entzündlichen Bedingungen

  2015cites this paper
• Preventive and therapeutic effects of Lactobacillus paracasei B21060-based synbiotic treatment on gut inflammation and barrier integrity in colitic mice.

  2015cites this paper
• Kefir treatment ameliorates dextran sulfate sodium-induced colitis in rats.

  2015cites this paper
• Different Dynamic Patterns of β-Lactams, Quinolones, Glycopeptides and Macrolides on Mouse Gut Microbial Diversity

  2015cites this paper
• Mechanisms and therapeutic effectiveness of lactobacilli

  2015cites this paper
• Paediatric Inflammatory Bowel Disease: A Mechanistic Approach to Investigate Exclusive Enteral Nutrition Treatment

  2014cites this paper
• A study on three aspects of Inflammatory Bowel Disease's Triad of Susceptibility: Hormones, Helminths and T regulatory cells, in the Helicobacter hepaticus mouse model for IBD

  2014cites this paper
• Metabolomic profiling in inflammatory bowel disease

  2014cites this paper
• In case of obesity, longevity-related mechanisms lead to anti-inflammation

  2014cites this paper
• Effect of salicin on gut inflammation and on selected groups of gut microbiota in dextran sodium sulfate induced mouse model of colitis

  2013cites this paper
• Inflammatory Bowel Disease Therapies and Gut Function in a Colitis Mouse Model

  2013cites this paper
• Association of gut microbiota with post-operative clinical course in Crohn’s disease

  2013cites this paper
• Oral Administration of Interleukin-10 and Anti-IL-1 Antibody Ameliorates Experimental Intestinal Inflammation

  2013cites this paper
• One year intermittent rifaximin plus fibre supplementation vs. fibre supplementation alone to prevent diverticulitis recurrence: a proof-of-concept study.

  2013cites this paper
• Efficacy profiles for different concentrations of Lactobacillus acidophilus in experimental colitis.

  2013cites this paper
• Medical management of Crohn’s disease

  2013cites this paper
• Microbiome and Host Interactions in Inflammatory Bowel Diseases: Relevance for Personalized Nutrition

  2013cites this paper
• REVIEWS: CURRENT TOPICS Nutritional protective mechanisms against gut inflammation☆

  2013cites this paper
• Nutritional protective mechanisms against gut inflammation.

  2013cites this paper
• Adipokines in the pathogenesis of idiopathic inflammatory bowel disease.

  2013cites this paper
• Osteoprotegerin Exerts Its Pro-inflammatory Effects Through Nuclear Factor-κB Activation

  2013cites this paper
• МЕХАНИЗМЫ ТРАНСЛОКАЦИИ БАКТЕРИАЛЬНОЙ АУТОФЛОРЫ В РАЗВИТИИ ЭНДОГЕННОЙ ИНФЕКЦИИ

  2013cites this paper
• A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis

  2013cites this paper
• Potential of probiotics as pharmaceutical agent: a review

  2013cites this paper
• Intestinal mucosal permeability of children with cefaclor-associated serum sickness-like reactions

  2013cites this paper
• Physiologically based pharmacokinetic models for the optimization of antiretroviral therapy: recent progress and future perspective

  2013cites this paper
• Innate immunity and inflammatory bowel disease: a review of clinical evidence and future application

  2013cites this paper
• Early endothelial damage and increased colonic vascular permeability in the development of experimental ulcerative colitis in rats and mice

  2012cites this paper
• Microbial Links to Inflammatory Bowel Disease Development: Potential Interventional Strategies in Treatment

  2012cites this paper
• Probiotics Applications in Autoimmune Diseases

  2012cites this paper
• epithelial bactericidal/permeability-increasing protein Functional and biochemical characterization of

  2012cites this paper
• Strategies of targeting oral drug delivery systems to the colon and their potential use for the treatment of colorectal cancer

  2012cites this paper
• JOINT MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE (IBD) – A CROSS-SECTIONAL STUDY WITH SPECIAL EMPHASIS ON RELATIONSHIP OF GUT FLORA TO BOWEL AND JOINT DISEASE

  2012cites this paper
• Inflammatory Diseases: Mechanisms and Natural Remedies

  2012cites this paper
• Comparison of simple Eudragit microparticles loaded with prednisolone and Eudragit-coated chitosan-succinyl-prednisolone conjugate microparticles: Part I. Particle characteristics and in vitro evaluation as a colonic delivery system

  2012cites this paper
• Probiotics in the Management of Inflammatory Bowel Disease

  2012cites this paper
• Nutraceuticals for protection and healing of gastrointestinal mucosa.

  2012influential citation
• Alternative Medicines as Emerging Therapies for Inflammatory Bowel Diseases

  2012cites this paper
• Engineered E. coli that detect and respond to gut inflammation through nitric oxide sensing.

  2012cites this paper
• Bifidobacterium lactis attenuates onset of inflammation in a murine model of colitis.

  2011cites this paper
• Update on the Management of Crohn’s Disease

  2011cites this paper
• Bacteria and pH-sensitive polysaccharide-polymer films for colon targeted delivery.

  2011cites this paper
• Systemic toll‐like receptor ligands modify B‐cell responses in human inflammatory bowel disease

  2011cites this paper
• The role of P-glycoprotein and breast cancer resistance protein (BCRP) in bacterial attachment to human gastrointestinal cells.

  2011cites this paper